N-Fmoc-N-[4-(tert-butoxy)-4-oxobutyl]glycine is a protected glycine derivative bearing a bulky tert-butoxy group that influences coupling behavior. The extended side chain enables exploration of steric effects and linker design. Researchers use it in constructing complex peptidomimetics and modular scaffolds. Its structure supports orthogonal synthetic strategies.
![N-Fmoc-N-[4-(tert-butoxy)-4-oxobutyl]glycine(CAS 174799-90-7)](https://img.creative-peptides.com/structure/174799-90-72d.png)
CAT No: R2128
CAS No:174799-90-7
Synonyms/Alias:174799-90-7;N-Fmoc-N-[4-(tert-butoxy)-4-oxobutyl]glycine;N-Fmoc-N-(4-(tert-butoxy)-4-oxobutyl)glycine;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(4-(tert-butoxy)-4-oxobutyl)glycine;{[4-(tert-butoxy)-4-oxobutyl][(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid;Fmoc-{tBuOCO(CH2)3}Gly-OH;MFCD32898814;CS-0439257;2-[9H-fluoren-9-ylmethoxycarbonyl-[4-[(2-methylpropan-2-yl)oxy]-4-oxobutyl]amino]acetic acid;
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More